Article Sidebar

pdf
Date Published: 04/03/2024
Abstract Views: 141
Views pdf: 92
DOI: https://doi.org/10.51298/vmj.v536i1.8663
Issue
Vol. 536 No. 1 (2024)
Section
Các bài báo
How to Cite
Phùng , T. H. ., Đỗ , A. T. ., Phan , K. T. ., & Nguyễn, T. L. . (2024). CLINICOPATHOLOGICAL CHARACTERISTICS OF PATIENTS WITH SYNCHRONOUS AND METACHRONOUS BREAST AND THYROID CANCER AT K HOSPITAL. Vietnam Medical Journal, 536(1). https://doi.org/10.51298/vmj.v536i1.8663

CLINICOPATHOLOGICAL CHARACTERISTICS OF PATIENTS WITH SYNCHRONOUS AND METACHRONOUS BREAST AND THYROID CANCER AT K HOSPITAL

Thị Huyền Phùng , Anh Tú Đỗ , Khánh Toàn Phan , Thanh Long Nguyễn

Main Article Content

Abstract

Purposes: To assess the clinicopathological characteristics of patients with synchronous and metachronous breast and thyroid cancer at K hospital. Methods: Cross-sectional study on 36 patients diagnosed with synchronous and metachronous breast cancer and thyroid cancer at K hospital from January 2020 to June 2023. Results: The mean age at the time of breast cancer diagnosis was 45.1 ± 8.6, at the time of thyroid cancer diagnosis was 46.0 ± 9.5. Most patients had stage I-II diseases. The main pathological type of breast cancer was invasive carcinoma NST (86.1%). The proportion of patients with hormone receptors positive breast cancer (ER or PR) was 69.4%, the proportion of Her2 positive breast cancer was 30.6%. The main pathological type of thyroid cancer was papillary carcinoma (94.4%). Conclusions: Patients with both breast cancer and thyroid cancer were often diagnosed at a relatively young age and at an early stage. The majority of patients had hormone receptor-positive breast cancer.

Article Details

References

1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209-249. doi:10.3322/ caac.21660
2. Kuo JH, Chabot JA, Lee JA. Breast cancer in thyroid cancer survivors: An analysis of the Surveillance, Epidemiology, and End Results-9 database. Surgery. 2016;159(1):23-30. doi:10. 1016/j.surg.2015.10.009
3. An JH, Hwangbo Y, Ahn HY, et al. A Possible Association Between Thyroid Cancer and Breast Cancer. Thyroid. 2015;25(12): 1330-1338. doi:10. 1089/thy.2014.0561
4. Advani PG, Morton LM, Kitahara CM, et al. Assessment of surveillance versus etiologic factors in the reciprocal association between papillary thyroid cancer and breast cancer. Cancer Epidemiol. 2021;74:101985. doi:10.1016/ j.canep. 2021.101985
5. Huang N, Chen X, Wei W, et al. Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancer. Cancer Med. 2018;7(12):6393-6400. doi:10.1002/ cam4.1856
6. Bolf EL, Sprague BL, Carr FE. A Linkage Between Thyroid and Breast Cancer: A Common Etiology? Cancer Epidemiol Biomarkers Prev. 2019;28(4): 643-649. doi:10.1158/1055-9965. EPI-18-0877
7. Ikeda Y, Kiyotani K, Yew PY, et al. Germline PARP4 mutations in patients with primary thyroid and breast cancers. Endocr Relat Cancer. 2016;23(3):171-179. doi: 10.1530/ERC-15-0359
8. Sun LM, Lin CL, Liang JA, Huang WS, Kao CH. Radiotherapy did not increase thyroid cancer risk among women with breast cancer: A nationwide population-based cohort study. Int J Cancer. 2015;137(12): 2896-2903. doi:10.1002/ ijc.29667
9. Zhang L, Wu Y, Liu F, Fu L, Tong Z. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer. Oncotarget. 2016;7(32): 52450-52459. doi:10. 18632/ oncotarget.9547
10. Tapia M, Hernando C, Martínez MT, et al. Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies. Cancers (Basel). 2023;15(18):4522. doi:10.3390/ cancers15184522